Learn with us

In this webinar, Dr Nneoma Okeke explores how AI and big data can transform infection prevention and control (IPC) from reactive to proactive. By analysing vast healthcare datasets, machine learning models can identify patients at high risk of infection in real time, enabling earlier, targeted interventions and more efficient use of resources. The session highlights the potential for personalised IPC strategies, improved patient outcomes, and smarter decision-making, while emphasising that AI supports (not replaces) clinical judgement. As this field evolves, integrating AI into routine IPC practice could unlock the full value of healthcare data and help prevent infections before they occur.

In this IPC Partners Journal Club, Jules Storr and Dr Claire Kilpatrick join Dr Jon Otter and Dr Phil Norville to explore how both what we do and how we communicate influence infection prevention and antimicrobial resistance (AMR) outcomes. The session examines two thought-provoking papers. The first highlights the critical (and often under-recognised) role of fundamental nursing care, such as oral care, hydration, mobilisation, and positioning, in preventing non-device associated healthcare-associated infections. The second explores how language shapes understanding and behaviour in AMR communication. It critiques commonly used metaphors, such as “war against superbugs” or “post-antibiotic apocalypse”, and raises important questions about whether current messaging drives meaningful action or unintended consequences. Together, the discussion challenges traditional IPC thinking, emphasising the importance of: - Bridging technical interventions with person-centred care - Recognising the impact of everyday clinical practices on infection outcomes - Using clearer, more thoughtful language to influence behaviour - Rethinking how we design and evaluate IPC communication strategies This session is essential for IPC professionals, clinicians, and researchers interested in improving practice through both evidence and communication. 👉 Don’t forget to subscribe for more IPC Partners webinars, journal clubs, and expert insights.

In this special IPC Partners Insight Webinar, recorded in partnership with the Healthcare Infection Society, Dr Jon Otter provides a timely, evidence-led overview of the evolving hantavirus situation. With increasing media attention and public concern, triggered by a cruise ship–linked outbreak, this session explores what we know (and don’t know) about hantavirus, with a clear focus on practical infection prevention and control (IPC). 🔍 What this webinar covers: - Current outbreak overview and global situation - Hantavirus epidemiology and transmission dynamics - Key differences between hantavirus strains (including Andes virus) - Incubation period, clinical features, and severity - Evidence for (and limits of) person-to-person transmission - Environmental survival and disinfection insights - Latest IPC guidance – including PPE, isolation, and cleaning protocols - Practical recommendations for healthcare and community settings 💡 Key takeaway: While hantavirus (particularly Andes virus) can cause severe illness, the overall risk to the general public remains very low, and it is not expected to behave like COVID-19. Early recognition, appropriate precautions, and evidence-based IPC measures are critical. 📅 This webinar attracted over 700 registrants and includes a live Q&A addressing real-world challenges from healthcare professionals.